Skip to main content

MDNAF · Medicenna Therapeutics Corp. · Shareholders & Ownership

Track MDNAF — free
$0.32 +0.03 (+10.41%) At close · Nov 6
Market Cap
$26.77M
Shares
92.30M
Volume · Nov 6 6800 Avg daily vol (3M) 46.75K

Every disclosed holder of MDNAF in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns MDNAF

13F quarter Dec 31, 2024

No chart: shares outstanding cannot be set against these holders.

Holder group Shares % Out
Institutional (13F) 175,000 —
Insiders (Forms 3, 4, 5) 0 —
13D/G-only blocks 32,631,090 —
Registered funds (N-PORT, not summed) 0 —

% Out is unavailable: a foreign private issuer reports ordinary shares, a different unit from the listed shares.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of MDNAF

# Holder Shares
1
Fahar Merchant
13G CIK 1845933 · Unknown · Dec 31, 2023
Rule 13d-1(d), exempt investor, unconfirmed, last confirmed Dec 31, 2023
20,244,255
2
RA CAPITAL MANAGEMENT, L.P.
13G CIK 1346824 · Registered investment adviser · Apr 30, 2024
Rule 13d-1(c), passive investor, unconfirmed, last confirmed Apr 30, 2024
7,714,760
3
Orin Hirschman
13G CIK 1131362 · Investment adviser · Dec 31, 2023
Rule 13d-1(c), passive investor, unconfirmed, last confirmed Dec 31, 2023
4,672,075
4
ORG Partners LLC
13F CIK 1979372 · Unknown · Dec 31, 2024
175,000

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1807983 CUSIP 58490H107 Visit website Investor relations